Keyphrases
Cell-based
100%
Virus-like
100%
COVID-19
100%
Virus
16%
Viral Proteins
16%
Vaccine Candidate
16%
Mucosal Immunity
16%
Novel Vaccines
16%
Non-infectious
16%
Antigen Presentation
16%
Viral Antigens
16%
Structural Proteins
16%
Causative Agents
16%
Intramuscular Injection
16%
Natural Infection
16%
Viral Gene
16%
Virus Structure
16%
Wild Type Virus
16%
Lentiviral Vector
16%
Human Cell Lines
16%
Genetic Material
16%
Nucleocapsid (N) Protein
16%
Non-replicating
16%
Natural Receptors
16%
Self-assembled Nanostructures
16%
COVID-19 Vaccine
16%
Medicine and Dentistry
Severe Acute Respiratory Syndrome Coronavirus 2
100%
Mammalian Cell
100%
Virus Like Agent
100%
Infection
16%
Cell Line
16%
Receptor
16%
Viral Protein
16%
Structural Protein
16%
Guanine Nucleotide Binding Protein
16%
Virus Nucleocapsid
16%
Antigen Presentation
16%
COVID-19
16%
Mucosal Immunity
16%
Intramuscular Injection
16%
Cell Antigen
16%
Lentivirus Vector
16%
Nanomaterial
16%
Virus Morphology
16%
COVID-19 Vaccine
16%
Biochemistry, Genetics and Molecular Biology
SARS Coronavirus
100%
Mammalian Cell
100%
Virus-Like Particle
100%
Wild Type
16%
Viral Protein
16%
Structural Protein
16%
Virus Nucleocapsid
16%
Antigen Presentation
16%
Virus Morphology
16%
Spike
16%
Lentivirus Vector
16%
Viral Genetics
16%
Mucosal Immunity
16%
G Protein
16%
Immunology and Microbiology
Virus-Like Particle
100%
Severe Acute Respiratory Syndrome Coronavirus 2
100%
COVID-19
33%
Wild Type
16%
Viral Protein
16%
Cell Line
16%
Human Cell
16%
Antigen Presentation
16%
Virus Nucleocapsid
16%
Virus Morphology
16%
Spike
16%
Mucosal Immunity
16%
Lentivirus Vector
16%
Cell Antigen
16%
Viral Genetics
16%
Pharmacology, Toxicology and Pharmaceutical Science
SARS Coronavirus
100%
Virus Like Agent
100%
Infection
16%
Receptor
16%
Structural Protein
16%
Guanine Nucleotide Binding Protein
16%
Viral Protein
16%
Cell Antigen
16%
Lentivirus Vector
16%
COVID-19 Vaccine
16%
Intramuscular Injection
16%
Nanomaterial
16%